Exercise as a therapeutic option for acute kidney injury: mechanisms and considerations for the design of future clinical studies

BMC Nephrol. 2020 Oct 23;21(1):446. doi: 10.1186/s12882-020-02098-9.

Abstract

Acute kidney injury (AKI) is a known risk factor for chronic kidney disease (CKD) and end stage kidney disease (ESKD). The progression from AKI to CKD, despite being well recognised, is not completely understood, although sustained inflammation and fibrosis are implicated. A therapeutic intervention targeting the post AKI stage could reduce the progression to CKD, which has high levels of associated morbidity and mortality. Exercise has known anti-inflammatory effects with animal AKI models demonstrating its use as a therapeutic agent in abrogating renal injury. This suggests the use of an exercise rehabilitation programme in AKI patients following discharge could attenuate renal damage and improve long term patient outcomes. In this review article we outline considerations for future clinical studies of exercise in the AKI population.

Keywords: Acute kidney injury; Exercise; Kidney disease; Rehabilitation; Therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Kidney Injury / metabolism
  • Acute Kidney Injury / pathology*
  • Acute Kidney Injury / rehabilitation*
  • Animals
  • Autophagy / physiology
  • Disease Models, Animal
  • Disease Progression
  • Exercise Therapy*
  • Fibrosis / prevention & control
  • Humans
  • Inflammation / prevention & control
  • Oxidation-Reduction
  • Renal Insufficiency, Chronic / prevention & control*
  • Risk Factors
  • Up-Regulation